1014-00003 · Optiwave Semiconductor Corp · Engagement & Client Intake

new-matter-intake-form.docx DOCUMENT Litigation

28 / 83 ← → ✕

CALDERWOOD & HARKNESS LLP

Counselors at Law

NEW MATTER INTAKE FORM

Form Version 4.2 — Rev. January 2022 Internal Reference: NMI-SF-2022-0478

CONFIDENTIALITY NOTICE: This New Matter Intake Form is prepared for internal use only and constitutes privileged and confidential attorney work product. This document is protected by the attorney-client privilege and the work product doctrine. Distribution outside Calderwood & Harkness LLP is strictly prohibited without the prior written authorization of the Responsible Partner or the firm's General Counsel. Unauthorized disclosure, reproduction, or dissemination of this document or any portion thereof is prohibited.

SECTION 1: MATTER IDENTIFICATION

This matter is opened in connection with a patent infringement enforcement action to be filed by the client on the plaintiff side. The matter has been assigned to the intellectual Property Group, Patent Litigation sub-group. This form documents all pertinent client, adverse party, staffing, financial, and substantive information required by the firm's New Client / New Matter Committee for approval to proceed. The conflict check was completed and cleared on May 9, 2022, prior to the execution of the engagement letter on the date set forth above.

SECTION 2: CLIENT INFORMATION

2.1 Client Entity Details

2.2 Primary Client Contact

Sandra Ellison serves as the primary point of contact for all legal matters associated with this engagement. All substantive correspondence, strategic memoranda, draft pleadings, and billing communications should be directed to Ms. Ellison unless otherwise instructed. Ms. Ellison has been with Optiwave Semiconductor Corp. since 2018 and has oversight responsibility for the company's litigation, IP licensing, and regulatory compliance functions.

2.3 Secondary Client Contact

Mr. Marchetti personally managed the prosecution of the patents-in-suit and has extensive familiarity with the prosecution histories, the prior art landscape, and the technical subject matter underlying each patent. Mr. Marchetti also drafted and sent the March 15, 2022 cease-and-desist letter to Lumos Photonics, Inc. with strategic input from this firm. He will serve as a critical resource throughout the litigation, particularly during claim construction briefing and preparation for the Markman hearing.

2.4 Client Executive Leadership

Dr. Ramanathan and Dr. Fong co-founded Optiwave Semiconductor Corp. in 2014 with the goal of commercializing advanced silicon photonics designs for high-bandwidth data center interconnects and telecommunications infrastructure. Both are named inventors on multiple patents-in-suit and will serve as key fact witnesses throughout the litigation. Their respective technical expertise and credibility before the court will be significant assets in this matter.

2.5 Majority Shareholder Information

Key Vantage Point Contacts:

• Douglas Fairbanks III, Managing Partner — Board member; primary decision-maker on litigation authorization and budget approval. Mr. Fairbanks personally approved the Board resolution authorizing this litigation on April 28, 2022. All material strategic decisions, including settlement authority and trial-or-settlement recommendations, require Mr. Fairbanks's concurrence.

• Rebecca Torres, Operating Partner, Semiconductor Sector — Board member with deep semiconductor industry expertise. Ms. Torres serves as the day-to-day reporting contact for Vantage Point on matters relating to OWS's strategic direction and competitive positioning. She will be briefed on case developments on a quarterly basis or more frequently as warranted.

Vantage Point Capital Partners' majority ownership position and board representation are material to this engagement because litigation authorization, budget approval, and settlement authority flow through the Board of Directors, on which Vantage Point exercises significant influence. The engagement team should ensure that all communications regarding material case developments are coordinated through Sandra Ellison with the understanding that Vantage Point representatives will be briefed as appropriate.

2.6 Primary Lender

The existence of FPCB's security interest in OWS's intellectual property assets is a material consideration for this matter. Under the terms of the revolving credit facility, OWS is required to provide notice to FPCB of the commencement of any material litigation. The engagement team should coordinate with Sandra Ellison to ensure that the required notification is delivered to FPCB contemporaneously with (or promptly following) the filing of the complaint. Additionally, the lien holder's interest in the IP assets may affect any potential settlement involving patent licensing or assignment, and should be analyzed in connection with any future settlement negotiations.

2.7 Existing Client Status

Optiwave Semiconductor Corp. is an existing client of Calderwood & Harkness LLP. The firm has previously represented OWS in corporate matters and IP counseling engagements handled through the firm's Palo Alto office. A comprehensive conflict check was completed and cleared on May 9, 2022. The Conflict Check Memorandum, prepared by the firm's General Counsel's Office, is attached to this form and documents the scope and results of the conflict review. No conflicts were identified with respect to the adverse party (Lumos Photonics, Inc.), its known counsel (Brannick Howell & Stein LLP), or any of the key individuals or entities identified in connection with this matter.

SECTION 3: MATTER DESCRIPTION

3.1 Matter Type and Practice Group

3.2 Brief Description of Matter

This engagement concerns the prosecution of a patent infringement action on behalf of Optiwave Semiconductor Corp. against Lumos Photonics, Inc. The complaint will assert infringement of four U.S. utility patents owned by OWS, each of which covers aspects of integrated waveguide coupling and photodetector architectures used in high-speed optical transceivers for data center and telecommunications applications. The patents-in-suit are as follows:

1. U.S. Patent No. 10,234,567 (the "'567 Patent") — "Integrated Waveguide Coupler with Tapered Mode Converter for Silicon Photonics Platforms"

2. U.S. Patent No. 10,891,234 (the "'234 Patent") — "Germanium-on-Silicon Photodetector with Graded Buffer Layer for Enhanced Responsivity"

3. U.S. Patent No. 11,045,678 (the "'678 Patent") — "Multi-Channel Optical Transceiver with Integrated Wavelength-Division Multiplexing on Silicon"

4. U.S. Patent No. 11,312,890 (the "'890 Patent") — "Driver Circuit Architecture for High-Speed Silicon Photonic Mach-Zehnder Modulators"

The patents-in-suit collectively address critical components of the silicon photonics signal chain, from waveguide coupling and optical detection to wavelength-division multiplexing and high-speed modulator driver circuitry. OWS's pre-suit investigation, conducted in coordination with this firm, indicates that the accused Lumos products incorporate each of these patented technologies.

3.3 Accused Products

The complaint will identify the following Lumos Photonics products as accused instrumentalities:

a. LumosBridge™ 800G Optical Engine. This is a co-packaged optics (CPO) engine designed for hyperscale data center switch applications. The LumosBridge™ integrates silicon photonics transceivers directly with switch ASICs to deliver 800 Gbps aggregate bandwidth. First shipped to customers in Q1 2022, the LumosBridge™ carries a unit price range of approximately $1,200 to $1,800 depending on volume and configuration. OWS's pre-suit technical analysis, based on publicly available product datasheets, conference presentations by Lumos engineers, and reverse engineering of a commercially obtained sample unit, indicates that the LumosBridge™ employs each of the patented architectures recited in the asserted claims.

b. LumosEdge™ 400ZR+ Pluggable Transceiver. This is a pluggable optical transceiver module in the QSFP-DD form factor, designed for data center interconnect (DCI) applications at distances up to 120 km. The LumosEdge™ has been in production and actively sold since Q3 2021, with a unit price range of approximately $600 to $900. The LumosEdge™ is Lumos's most commercially successful product to date and is deployed by multiple hyperscale cloud operators and Tier 1 telecommunications carriers.

3.4 Claims Sought

The complaint will seek the following relief:

• Monetary Damages. Based on a reasonable royalty theory, OWS's pre-suit damages analysis estimates total damages in excess of $75 million. This estimate applies an estimated royalty rate of 7.5% to approximately $148.6 million in combined accused product revenue for calendar year 2022, inclusive of pre-suit damages and projected post-filing revenue. The damages estimate will be refined following the retention of a damages expert and the completion of discovery.

• Injunctive Relief. OWS intends to seek a permanent injunction barring Lumos from making, using, selling, offering for sale, or importing the accused products in the United States.

• Enhanced Damages. OWS intends to seek enhanced damages under 35 U.S.C. § 284, based on evidence of willful infringement. The basis for willfulness includes Lumos's actual knowledge of the '567 and '234 Patents as evidenced by the cease-and-desist letter dated March 15, 2022, and Lumos's continued sales of accused products notwithstanding such knowledge.

• Attorneys' Fees. OWS intends to seek an award of attorneys' fees under 35 U.S.C. § 285, to the extent the case is found to be "exceptional."

• Costs. Recovery of all taxable costs of the action.

3.5 Pre-Suit Activity

The following pre-suit activities have been undertaken in connection with this matter:

• March 15, 2022: OWS, through its VP of intellectual Property Ted Marchetti, sent a detailed cease-and-desist letter to Lumos Photonics, Inc. at its Austin, Texas headquarters. The letter identified U.S. Patent Nos. 10,234,567 and 10,891,234, described the basis for OWS's belief that the LumosBridge™ and LumosEdge™ products infringe the identified patents, and demanded that Lumos cease all infringing activity and enter into licensing discussions. The letter was prepared with strategic input from Calderwood & Harkness.

• April 4, 2022: Lumos Photonics responded through its General Counsel, Richard Talbot, denying infringement and asserting that the patents identified in the cease-and-desist letter are invalid in view of prior art. The response did not identify specific prior art references or provide a detailed non-infringement analysis. The response did not propose licensing discussions or offer any alternative resolution.

• April 28, 2022: The OWS Board of Directors convened and, upon the recommendation of General Counsel Sandra Ellison and after consultation with Vantage Point Capital Partners, adopted a resolution authorizing the filing of a patent infringement action against Lumos Photonics. The Board resolution authorized the retention of Calderwood & Harkness LLP as outside litigation counsel and approved a litigation budget of $4.2 million through trial.

3.6 Client Authorization

The client's authorization to proceed with this litigation is memorialized in the Board resolution dated April 28, 2022. The resolution was adopted with the concurrence of Vantage Point Capital Partners, which holds three of seven Board seats. A copy of the Board resolution is to be obtained from the client and placed in the matter file. Sandra Ellison has confirmed the existence and scope of the Board authorization and has represented that she possesses full authority to direct the engagement on behalf of OWS.

SECTION 4: ADVERSE PARTY INFORMATION

4.1 Adverse Party Entity Details

4.2 Additional Offices Relevant to This Matter

Lumos Photonics maintains facilities beyond its Austin headquarters that are relevant to this litigation, particularly for purposes of venue and personal jurisdiction analysis:

• Sales Office and Engineering Center: 4750 Great America Parkway, Suite 320, Santa Clara, CA 95054. This office houses sales personnel and design engineers and is the primary point of contact for Lumos's Northern California customer base, including hyperscale data center operators headquartered in the San Jose / Santa Clara area.

• Fabrication Facility: 3200 NE Shute Road, Hillsboro, OR 97124. Lumos operates its own wafer fabrication facility at this location, where certain silicon photonics components are manufactured. This facility is relevant to manufacturing process comparisons and to the question of whether accused products are "made" in a manner that falls within the scope of the asserted patent claims.

4.3 Public Company Information

Lumos's publicly traded status and its market capitalization and revenue figures are relevant to multiple aspects of this litigation, including damages calculations (as a proxy for the accused products' commercial significance), the assessment of Lumos's financial capacity to sustain protracted litigation, and the potential impact of litigation-related disclosures on Lumos's stock price and investor relations, which may influence settlement dynamics.

4.4 Largest Institutional Shareholder

4.5 Adverse Party Key Personnel

Dr. Mei-Lin Chen and Dr. Nikolai Petrov are expected to be key witnesses for Lumos on technical issues, particularly with respect to the design and operation of the accused products and any non-infringement positions. Richard Talbot authored the April 4, 2022 response letter denying infringement and will likely oversee the defense of this matter for Lumos, though outside counsel will handle the litigation itself.

4.6 Registered Agent in California

Service of process upon Lumos's registered agent in California is a viable option for initiating this action, consistent with applicable rules of civil procedure and the Federal Rules of Civil Procedure.

4.7 Expected Adverse Counsel

Victoria Ashworth is a well-known IP litigator in the Northern District of California and is known for aggressive claim construction briefing and Markman hearing advocacy. She has tried multiple patent cases in the technology sector and has a strong track record at the Federal Circuit. The engagement team should anticipate a vigorous defense, including early-stage inter partes review (IPR) petitions, aggressive claim construction positions, and well-resourced expert testimony. Prior case analysis of Ms. Ashworth's recent matters should be conducted by the team to inform litigation strategy.

SECTION 5: STAFFING AND TIMEKEEPERS

5.1 Engagement Team

The following attorneys have been assigned to this matter. Given the highly technical nature of the subject matter — involving silicon photonics, waveguide coupling, germanium photodetector epitaxy, wavelength-division multiplexing, and high-speed CMOS driver circuit design — all team members possess relevant engineering or physical science backgrounds in addition to their legal credentials.

5.1.1 Responsible Partner

Mr. Ngo will serve as the Responsible Partner and lead trial counsel for this engagement. He brings over two decades of patent litigation experience in the semiconductor and photonics sectors, including multiple jury trials in the Northern District of California and the Eastern District of Texas. His electrical engineering background and patent bar registration enable him to engage directly with the technical subject matter at the claim construction, infringement analysis, and expert testimony stages.

5.1.2 Billing Partner

Mr. Delgado manages the client billing relationship and oversees compliance with the fee arrangement, including discount application, retainer management, and quarterly budget reporting to the client. Mr. Delgado is a signatory to the engagement letter and will review all invoices prior to submission to the client.

5.1.3 Lead Associate

Mr. Siddiqui's graduate-level training in electrical engineering, with a focus on photonics and semiconductor device physics, makes him an ideal resource for this matter. He will take the lead on claim construction analysis and briefing, coordinate fact and expert discovery, and assist with deposition preparation of both fact and expert witnesses.

5.1.4 Working Associate

Ms. Bauer's physics background and her prior experience with semiconductor patent litigation matters at Calderwood & Harkness position her well to contribute to the technical analysis required in this case. She will support infringement contention preparation, invalidity analysis, and legal research on claim construction and patent damages issues.

5.1.5 Additional Staffing Notes

The technical subject matter of this litigation — involving silicon photonics integrated circuit design, waveguide optics, germanium-on-silicon photodetector fabrication, wavelength-division multiplexing architectures, and high-speed CMOS driver circuits — requires team members with substantive engineering or physical science backgrounds. All four assigned team members possess relevant technical credentials, as reflected above. Should additional staffing be required (e.g., for document review during discovery or for trial preparation), the team will prioritize the assignment of attorneys with engineering or science backgrounds to the extent available within the firm's IP Group.

Additional staffing needs may arise as the case progresses, particularly during the discovery phase and in connection with trial preparation. Any changes to the staffing plan will be communicated to the client and reflected in updated budget estimates.

SECTION 6: BILLING AND FEE ARRANGEMENT

6.1 Fee Arrangement Type

The fee arrangement for this engagement is hourly billing with a blended rate structure and a volume discount, as set forth in the engagement letter dated May 12, 2022. The engagement letter was executed by Alan Ngo and Marcus Delgado on behalf of Calderwood & Harkness LLP, and by Sandra Ellison on behalf of Optiwave Semiconductor Corp.

6.2 Standard and Effective Billing Rates

The following table sets forth the standard billing rates and the effective billing rates (after application of a 10% volume discount) for each assigned timekeeper:

The 10% volume discount is applied to all standard billing rates and reflects the anticipated volume and duration of this engagement, as well as the firm's existing and ongoing relationship with OWS. The discount is subject to the terms and conditions set forth in the engagement letter and may be revisited in connection with any material changes to the scope of the engagement.

6.3 Retainer

The initial retainer deposit of $100,000 was received from OWS on May 16, 2022, and an acknowledgment letter confirming receipt was sent on May 18, 2022. The retainer is maintained in the firm's client trust account (IOLTA) in accordance with applicable rules of professional conduct. The retainer will be replenished on a quarterly basis to maintain the $100,000 balance, with fees drawn against the retainer as invoiced and approved by the client.

6.4 Engagement Letter

The engagement letter governing this matter was fully executed on May 12, 2022. The engagement letter sets forth the scope of the engagement, the fee arrangement, the retainer terms, billing procedures, expense reimbursement policies, conflict waiver provisions (if any), and the termination and withdrawal provisions applicable to the engagement. A copy of the fully executed engagement letter is attached to this form.

SECTION 7: BUDGET AND FINANCIAL ESTIMATES

7.1 Estimated Total Budget

The estimated total budget of $4.2 million encompasses all anticipated legal fees and costs from the pre-suit investigation and complaint drafting phase through the conclusion of trial. This budget reflects the complexity of the four-patent case, the expected duration of the litigation (estimated 24–30 months to trial), and the resource-intensive nature of patent litigation in the Northern District of California, including claim construction proceedings, extensive fact and expert discovery, dispositive motions practice, and trial.

7.2 Budget Breakdown by Phase

The following phase-based budget breakdown represents the firm's current estimates based on the anticipated scope and complexity of the litigation. These estimates are subject to revision as the case develops and will be updated on a quarterly basis in connection with budget review reporting to the client.

These estimates include attorney fees at the effective (Discounted) billing rates set forth in Section 6 above, but do not include expert witness fees and costs, which are estimated separately below. The estimates also do not include certain categories of out-of-pocket costs (e.g., court filing fees, service of process costs, deposition transcript fees, travel expenses, and electronic discovery vendor costs), which will be billed to the client as incurred in accordance with the engagement letter.

7.3 Expert Costs

Expert witness fees and costs are not included in the $4.2 million budget set forth above and will be billed separately to the client. The following experts are anticipated to be retained in connection with this matter:

7.3.1 Technical Expert

Dr. Whitfield is a recognized authority in silicon photonics device design and has served as a technical expert in multiple patent litigation matters in this technology area. His academic credentials, publication record, and practical industry consulting experience are expected to provide substantial credibility before the court. Estimated expert fees for Dr. Whitfield are expected to range from $300,000 to $450,000 through trial, depending on the scope and duration of discovery and the need for rebuttal work.

7.3.2 Damages Expert

Dr. Kessler is an experienced damages expert who has testified in numerous patent infringement actions involving semiconductor and electronics technologies. His engagement will encompass the preparation of a comprehensive damages report applying the reasonable royalty framework, analysis of the Georgia-Pacific factors, and, if warranted by the evidence developed during discovery, a supplemental analysis of lost profits. Estimated expert fees for Dr. Kessler are expected to range from $200,000 to $350,000 through trial.

7.4 Pre-Litigation Patent Portfolio Valuation

Clearpath IP Valuation Services conducted a pre-litigation valuation of OWS's patent portfolio, including a specific valuation of the four patents asserted in this action. The valuation was performed using a combination of income-based and market-based approaches and serves as a reference point for the damages analysis. The Clearpath valuation report is on file with the engagement team. The portfolio-level valuation of $215 million also provides context for the significance of OWS's IP assets as collateral under the FPCB revolving credit facility.

7.5 Third-Party Litigation Funding

OWS and Vantage Point Capital Partners considered the use of third-party litigation funding to offset the costs of this action. Resolute Litigation Finance, LP provided a term sheet outlining the proposed funding structure, including the funder's proposed return on investment and the conditions under which funding would be provided and repaid. After review, OWS and Vantage Point declined the Resolute term sheet in favor of self-funding. The decision to self-fund reflects Vantage Point's confidence in the strength of the claims and the availability of sufficient capital within the fund to support the litigation through trial without diluting the potential recovery. The Resolute term sheet is on file for reference.

SECTION 8: FORUM AND JURISDICTIONAL INFORMATION

8.1 Expected Forum

The Northern District of California, San Jose Division, is the preferred forum for this action. The San Jose Division has a well-established history of patent litigation in the semiconductor and photonics technology sectors, and several judges in the division have extensive experience with the technical and procedural complexities of patent cases. The patent local rules in the Northern District provide a structured framework for claim construction proceedings and case management that is favorable to an efficient prosecution of this four-patent case.

8.2 Subject Matter Jurisdiction

Subject matter jurisdiction is proper under 28 U.S.C. §§ 1331 and 1338(a). This action arises under the patent laws of the United States, specifically 35 U.S.C. § 271, which provides for civil actions against parties who make, use, offer to sell, sell, or import patented inventions within the United States without authorization. Federal courts have exclusive original jurisdiction over civil actions arising under the patent laws.

8.3 Venue

Venue is proper in the Northern District of California under 28 U.S.C. § 1400(b), the patent venue statute. Lumos Photonics, Inc. maintains a permanent and continuous business establishment within the Northern District in the form of a sales office and engineering center located at 4750 Great America Parkway, Suite 320, Santa Clara, California 95054. Additionally, Lumos has committed alleged acts of infringement within the Northern District through the sale of accused products to hyperscale data center customers headquartered within the district. Under the Supreme Court's decision in TC Heartland LLC v. Kraft Foods Group Brands LLC, 581 U.S. 258 (2017), and the Federal Circuit's subsequent guidance in In re Cray Inc., 871 F.3d 1355 (Fed. Cir. 2017), the existence of Lumos's Santa Clara office constitutes a "regular and established place of business" within the meaning of § 1400(b).

8.4 Personal Jurisdiction

The court has personal jurisdiction over Lumos Photonics based on the following contacts with California and the Northern District:

• Lumos is registered to do business in the State of California.

• Lumos maintains permanent employees at its Santa Clara office, including sales personnel and design engineers who are engaged in the marketing, sale, and technical support of the accused products.

• Lumos generates approximately 22% of its U.S. revenue from customers headquartered or located in the Northern District of California.

• Lumos has directed sales and marketing activities toward customers in the Northern District, including the sale of the accused LumosBridge™ and LumosEdge™ products to hyperscale data center operators and telecommunications companies with operations in the district.

These contacts are sufficient to establish both general and specific personal jurisdiction over Lumos in the Northern District of California.

8.5 Target Filing Date

The complaint is being prepared for filing on or about June 3, 2022. This target date allows sufficient time for the finalization of the complaint, the completion of pre-filing procedural requirements, and the coordination of concurrent client notifications (including the FPCB notification discussed in Section 2.6 above).

8.6 Statute of Limitations and Laches Considerations

Under 35 U.S.C. § 286, no recovery shall be had for any infringement committed more than six years prior to the filing of the complaint. The earliest-issued patent-in-suit (the '567 Patent) was issued on March 19, 2019, and the most recently issued patent (the '890 Patent) was issued on April 26, 2022. Based on the current target filing date, no statute of limitations issue arises for any of the patents-in-suit.

The pre-suit damages period, encompassing accused product sales from the inception of infringement through the anticipated filing date, is estimated as follows:

• The LumosEdge™ 400ZR+ has been in production and sold since Q3 2021.

• The LumosBridge™ 800G was first shipped in Q1 2022.

• Accused product revenue during the pre-suit period (approximately Q3 2021 through Q2 2022) is estimated at $62.3 million.

Laches is no longer an affirmative defense in patent cases following the Supreme Court's decision in SCA Hygiene Products Aktiebolag v. First Quality Baby Products, LLC, 580 U.S. 328 (2017), but unreasonable delay in bringing suit could affect equitable considerations, including the availability of injunctive relief. The engagement team has determined that no laches concern exists given the relatively short period between the identification of infringement, the sending of the cease-and-desist letter, and the filing of the complaint.

SECTION 9: PATENTS-IN-SUIT — DETAILED SUMMARY

This section provides a detailed summary of each patent-in-suit, including key bibliographic data, asserted claims, key claim limitations presenting potential vulnerabilities, and prosecution history notes relevant to the infringement and validity analysis.

9.1 U.S. Patent No. 10,234,567 — The '567 Patent

Key Claim Limitation — "Adiabatically Coupled": The asserted claims of the '567 Patent recite an "adiabatically coupled" waveguide structure, which is central to the patented mode converter architecture. This limitation presents a potential vulnerability because Lumos's accused LumosBridge™ and LumosEdge™ products are believed to employ a segmented taper design rather than a continuous adiabatic taper. The question of whether a segmented taper qualifies as "adiabatically coupled" within the meaning of the claims will be a critical issue at claim construction. The specification describes the adiabatic coupling as achieving low-loss mode conversion through gradual geometric transitions, but does not expressly address segmented or discrete-step taper geometries.

Prosecution History Note: The '567 Patent was subject to two office action rejections during prosecution. During prosecution, the claims were narrowed through amendment to include the "adiabatically coupled" limitation in order to overcome a prior art rejection based on Tanaka et al., U.S. Patent No. 9,456,012, issued September 6, 2016. The Tanaka reference is a prior OWS-related patent that ironically lists Hideo Tanaka — a former OWS engineer and named inventor on the '567 Patent — as a co-inventor. The amendment and the applicant's accompanying remarks distinguishing the Tanaka reference create prosecution history estoppel risk under the doctrine of equivalents, which may limit OWS's ability to capture Lumos's segmented taper design under an equivalents theory if the literal infringement argument based on "adiabatically coupled" does not succeed.

9.2 U.S. Patent No. 10,891,234 — The '234 Patent

Key Claim Limitation — "Graded Buffer Layer Having a Continuously Varying Germanium Concentration": The asserted claims of the '234 Patent recite a photodetector structure incorporating a "graded buffer layer having a continuously varying germanium concentration." This limitation presents a significant vulnerability because OWS's pre-suit technical analysis indicates that Lumos's accused products employ a step-graded SiGe buffer layer with four discrete germanium concentration fractions (0.25, 0.50, 0.75, and 1.0), rather than a continuously varying germanium gradient. The distinction between "continuously varying" and "step-graded" buffer layers is a well-understood concept in semiconductor epitaxy, and defendant can be expected to argue that Lumos's discrete-step approach falls outside the scope of the "continuously varying" limitation.

Prosecution History Note: The '234 Patent was allowed on the first office action following an examiner interview. Notably, the specification of the '234 Patent describes both "continuously graded" and "step-graded" embodiments as alternative approaches to achieving the graded buffer layer. However, the claims as allowed recite only "continuously varying" germanium concentration and do not encompass the "step-graded" embodiment described in the specification. This discrepancy between the specification's broader disclosure and the narrower claim language creates a risk that the court will construe "continuously varying" to exclude step-graded structures, potentially precluding literal infringement. The engagement team should evaluate whether a doctrine of equivalents argument is viable for capturing Lumos's step-graded design and should assess the strength of the intrinsic evidence supporting such an argument.

9.3 U.S. Patent No. 11,045,678 — The '678 Patent

Key Claim Limitation — "Monolithically Formed on a Single Silicon Die": The asserted claims of the '678 Patent recite a multi-channel optical transceiver architecture in which the wavelength-division multiplexing components are "monolithically formed on a single silicon die." This limitation presents a risk of narrow construction because Lumos's accused products are believed to employ a micro-transfer-printed III-V (indium phosphide) gain element that is bonded to the silicon photonic integrated circuit (PIC) die, rather than a purely monolithic silicon-based approach. Lumos can be expected to argue that its heterogeneous integration approach — in which III-V gain elements are separately fabricated and then bonded to the silicon PIC — does not meet the "monolithically formed" limitation.

Prosecution History Note: The '678 Patent was subject to three office actions during prosecution. The "monolithically formed" limitation was added by amendment during prosecution to overcome prior art references describing hybrid or heterogeneous integration approaches. The applicant's remarks accompanying the amendment expressly distinguished heterogeneous integration approaches in which components are separately fabricated and subsequently bonded to the silicon platform. This prosecution history creates a significant estoppel risk that will constrain OWS's ability to argue that "monolithically formed" should be construed broadly enough to encompass Lumos's micro-transfer-printing approach. The engagement team should carefully analyze the applicant's arguments of record to assess the scope of the estoppel and to determine whether any distinction can be drawn between the prior art discussed during prosecution and Lumos's specific implementation.

9.4 U.S. Patent No. 11,312,890 — The '890 Patent

Key Claim Limitation — "Pre-Emphasis Equalization Stage Electrically Co-Integrated with the Modulator on a Common Substrate": The asserted claims of the '890 Patent recite a driver circuit architecture in which the pre-emphasis equalization stage is "electrically co-integrated with the modulator on a common substrate." This limitation presents a vulnerability because Lumos's accused products employ a separate CMOS driver die that is flip-chip bonded to the silicon photonics die via copper pillar micro-bumps. The Lumos architecture places the driver circuit on a distinct semiconductor die (fabricated in a standard CMOS process) that is mechanically and electrically interconnected with the modulator die through the micro-bump bonding process, rather than integrating the driver and modulator on a single common substrate.

Prosecution History Note: The '890 Patent was subject to two office actions during prosecution. The "co-integrated" limitation was added by amendment to distinguish prior art describing separately fabricated and bonded driver circuits. The applicant's remarks accompanying the amendment drew a clear distinction between "co-integrated" driver-modulator architectures (in which the driver and modulator are fabricated on the same substrate) and multi-die packaging approaches (in which separately fabricated dies are interconnected through bonding or packaging techniques). This prosecution history directly implicates the Lumos product architecture and creates prosecution history estoppel risk that may preclude a doctrine of equivalents argument if the literal infringement position on the "co-integrated" limitation is unsuccessful.

Additional Note: The '890 Patent was issued on April 26, 2022, during the pre-suit investigation period. Because the patent was issued very recently, there is no prior art challenge based on the six-year damages limitation under 35 U.S.C. § 286. However, the recency of issuance means that there has been minimal post-issuance scrutiny of the patent, and defendant may seek to challenge validity through inter partes review proceedings at the Patent Trial and Appeal Board (PTAB) in addition to or in lieu of raising invalidity defenses in the district court litigation.

SECTION 10: RELATED MATTERS AND DOCKET INFORMATION

10.1 Related Prior or Pending Matters

No related prior or pending matters involving these parties, these patents, or substantially similar subject matter are known to exist at this firm or in the public docket. A review of PACER and the PTAB's trial records confirms that no prior litigation or inter partes review proceedings have been filed with respect to any of the four patents-in-suit.

10.2 Prior Counsel

No prior outside counsel was engaged for this matter. OWS's internal intellectual property function, under the direction of VP of IP Ted Marchetti, handled the initial infringement analysis and the drafting and sending of the March 15, 2022 cease-and-desist letter. Calderwood & Harkness provided strategic input on the cease-and-desist letter but was not formally engaged as litigation counsel until the execution of the engagement letter on May 12, 2022.

10.3 Contract Foundry

Pinnacle Semiconductor Foundry is OWS's contract manufacturing partner for the fabrication of its silicon photonics integrated circuits. The foundry relationship is relevant to this litigation because manufacturing process comparisons may arise during the claim construction and infringement analysis phases, particularly with respect to the "monolithically formed" limitation of the '678 Patent and the "co-integrated" limitation of the '890 Patent. Additionally, confidentiality obligations under OWS's foundry agreement with Pinnacle may affect the scope of discovery and may require the entry of a protective order governing the production of manufacturing-related documents.

SECTION 11: KEY CLIENT PERSONNEL FOR LITIGATION

The following individuals have been identified as key OWS and Vantage Point personnel for purposes of this litigation. Each individual's relevance to the case is described below.

Special Note Regarding Hideo Tanaka and Rajesh Iyer: The engagement team should prioritize early witness interviews with Hideo Tanaka and Rajesh Iyer. Both individuals occupy sensitive dual roles as named inventors on patents-in-suit and as authors/inventors of prior art references that defendant is expected to assert in support of invalidity defenses. The factual and evidentiary issues surrounding these individuals will require careful management throughout the litigation. In particular:

• Hideo Tanaka departed OWS in 2019 and is no longer employed by the client. His current employment status and any potential conflicts of interest (e.g., current employment by Lumos or a Lumos competitor) must be investigated promptly. His testimony regarding the relationship between the '567 Patent and U.S. Patent No. 9,456,012 will be critical to the claim construction and invalidity phases of the case.

• Rajesh Iyer remains employed by OWS as a circuit designer. His 2018 IEEE article, co-authored with Patel, may constitute prior art under 35 U.S.C. §§ 102 or 103 with respect to the '890 Patent, depending on the publication date relative to the patent's effective filing date and the scope of the article's disclosure. The engagement team should obtain a copy of the article, analyze its disclosure against the claims of the '890 Patent, and assess whether any safe harbor or exception (e.g., the one-year grace period under § 102(b)(1)(A) for inventor disclosures) applies.

SECTION 12: SPECIAL CONSIDERATIONS AND RISK FACTORS

This section identifies the material risks, strategic considerations, and special circumstances that the engagement team and the firm's New Client / New Matter Committee should evaluate in connection with the approval of this engagement.

12.1 Claim Construction Risk

The pre-suit assessment identifies significant risk that key claim terms in each of the four patents-in-suit could be narrowly construed by the court in a manner that excludes Lumos's accused product designs from the scope of the asserted claims. The claim construction (Markman) hearing will be the most critical juncture in this litigation, and the outcome of the Markman proceedings will be substantially determinative of the overall case viability.

The key claim terms presenting the greatest risk are:

1. "Adiabatically coupled" ('567 Patent) — Risk that Lumos's segmented taper design will be excluded if the term is construed to require a continuous, gradual geometric transition rather than a segmented or discrete-step approach.

2. "Continuously varying germanium concentration" ('234 Patent) — Risk that Lumos's step-graded SiGe buffer layer (four discrete germanium fractions: 0.25, 0.50, 0.75, 1.0) will be excluded if the term is construed to require a smooth, continuous gradient rather than discrete steps.

3. "Monolithically formed" ('678 Patent) — Risk that Lumos's micro-transfer-printed III-V gain elements bonded to the silicon PIC will be excluded under a narrow construction requiring all components to be fabricated on a single substrate without heterogeneous bonding or transfer-printing techniques.

4. "Co-integrated" ('890 Patent) — Risk that Lumos's separately fabricated CMOS driver die flip-chip bonded via copper pillar micro-bumps will be excluded under a construction requiring the driver and modulator to be fabricated on a common substrate without separate die-level integration.

The engagement team should conduct a thorough claim construction analysis prior to filing, prepare comprehensive claim construction briefs, and retain Dr. Harold Whitfield as a technical expert to support the firm's claim construction positions. The team should also prepare for the possibility that an adverse Markman ruling on one or more claim terms may necessitate a reassessment of the case and, potentially, early settlement discussions.

12.2 Prior Art / Invalidity Risk

Defendant is expected to assert invalidity under 35 U.S.C. §§ 102 (novelty), 103 (obviousness), and 112 (written description and enablement). The following prior art references have been identified as the most significant threats:

• Tanaka et al., U.S. Patent No. 9,456,012 (issued September 6, 2016) — This patent, which describes a waveguide coupling structure, was cited by the examiner during prosecution of the '567 Patent and was the basis for the narrowing amendment that added the "adiabatically coupled" limitation. The Tanaka reference is particularly sensitive because its co-inventor, Hideo Tanaka, is also a named inventor on the '567 Patent and a former OWS employee. Defendant can be expected to argue that the '567 Patent claims are obvious over Tanaka in combination with other references.

• Chen & Liu (2016 journal article) — This peer-reviewed journal article describes germanium-on-silicon photodetector structures with graded buffer layers. The article may be asserted as anticipatory prior art or as an obviousness reference against the '234 Patent, depending on its specific disclosure relative to the "continuously varying germanium concentration" limitation.

• Nordlicht, EP 3,234,567 A1 (published August 2, 2017) — This European patent application describes multi-channel optical transceiver architectures with integrated WDM on silicon platforms. The Nordlicht reference may be asserted against the '678 Patent, particularly if it discloses a monolithic integration approach.

• Iyer & Patel (2018 IEEE article) — This article, co-authored by OWS's own Rajesh Iyer (named inventor on the '890 Patent), describes driver circuit architectures for silicon photonic Mach-Zehnder modulators. The article may constitute prior art against the '890 Patent under § 102 or § 103. The engagement team must determine the precise publication date of the article relative to the November 15, 2018 filing date of the '890 Patent and assess whether the one-year grace period for inventor disclosures under § 102(b)(1)(A) applies.

Additionally, Lumos may file one or more inter partes review (IPR) petitions at the PTAB, seeking to invalidate the patents-in-suit on anticipation or obviousness grounds. The filing of IPR petitions is a common defense strategy in patent litigation and could result in the cancellation of some or all of the asserted claims. The engagement team should be prepared to respond to IPR petitions and to address the potential impact of parallel PTAB proceedings on the district court litigation schedule.

12.3 Prosecution History Estoppel

Prosecution history estoppel presents a significant risk for two of the four patents-in-suit:

• '567 Patent: The narrowing amendment adding the "adiabatically coupled" limitation to overcome the Tanaka prior art creates estoppel under the Supreme Court's Festo framework, potentially precluding a doctrine of equivalents argument to reach Lumos's segmented taper design if the literal infringement argument fails.

• '678 Patent: The narrowing amendment adding the "monolithically formed" limitation to overcome hybrid integration prior art creates estoppel that may preclude an equivalents argument to reach Lumos's micro-transfer-printing approach.

For the '234 Patent and the '890 Patent, prosecution history estoppel is less pronounced but should be analyzed in light of any examiner interviews or applicant remarks on the record that may bear on the construction of the key claim limitations.

12.4 Lender Notification Requirement

As discussed in Section 2.6, OWS's revolving credit facility with First Pacific Commerce Bank, N.A. requires notification of material litigation involving the company's intellectual property assets. The filing of this patent infringement action — while plaintiff-side — constitutes a material litigation event because the patents-in-suit are among the IP assets that serve as partial collateral under the credit facility. The engagement team should coordinate with Sandra Ellison to ensure that the required notification is delivered to FPCB promptly upon filing. Failure to provide timely notification could constitute a covenant violation under the credit facility, potentially triggering cross-default provisions.

12.5 Litigation Funding Decision

As discussed in Section 7.5, OWS and Vantage Point Capital Partners considered and declined a third-party litigation funding arrangement with Resolute Litigation Finance, LP. The decision to self-fund the litigation means that OWS and Vantage Point bear the full financial risk of the litigation, including the possibility of an unfavorable outcome, a protracted discovery phase, and trial costs that may exceed the current budget estimate. However, self-funding also preserves OWS's full recovery in the event of a favorable judgment or settlement and avoids the disclosure and reporting obligations typically associated with litigation funding arrangements.

12.6 OWS Patent Portfolio

OWS holds a substantial patent portfolio consisting of 87 issued U.S. utility patents and 14 pending patent applications. The portfolio is concentrated in the following technology areas: waveguide coupling architectures, germanium-on-silicon photodetector structures, modulator driver circuit designs, and silicon photonics integration methods. The four patents asserted in this litigation represent a strategically important subset of the overall portfolio, and the outcome of this litigation may have implications for the value and enforceability of the broader portfolio. The pre-litigation patent portfolio valuation conducted by Clearpath IP Valuation Services assigned a total portfolio value of $215 million and a collective value of $42.8 million to the four asserted patents.

SECTION 13: APPROVALS AND SIGNATURES

The undersigned confirm that the information set forth in this New Matter Intake Form is accurate and complete to the best of their knowledge, and that all required conflict checks, client verifications, and internal approvals have been obtained or are in the process of being obtained.

13.1 Responsible Partner